Krystal Biotech (KRYS) Return on Capital Employed: 2021-2025
Historic Return on Capital Employed for Krystal Biotech (KRYS) over the last 4 years, with Sep 2025 value amounting to 0.14%.
- Krystal Biotech's Return on Capital Employed rose 11.00% to 0.14% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.14%, marking a year-over-year increase of 11.00%. This contributed to the annual value of 0.08% for FY2024, which is 25.00% up from last year.
- Krystal Biotech's Return on Capital Employed amounted to 0.14% in Q3 2025, which was up 5.46% from 0.14% recorded in Q2 2025.
- In the past 5 years, Krystal Biotech's Return on Capital Employed registered a high of 0.14% during Q3 2025, and its lowest value of -0.28% during Q1 2023.
- Over the past 3 years, Krystal Biotech's median Return on Capital Employed value was -0.03% (recorded in 2024), while the average stood at -0.05%.
- In the last 5 years, Krystal Biotech's Return on Capital Employed declined by 14bps in 2022 and then rose by 24bps in 2024.
- Krystal Biotech's Return on Capital Employed (Quarterly) stood at -0.13% in 2021, then declined by 14bps to -0.27% in 2022, then climbed by 13bps to -0.14% in 2023, then rose by 21bps to 0.07% in 2024, then increased by 11bps to 0.14% in 2025.
- Its Return on Capital Employed stands at 0.14% for Q3 2025, versus 0.14% for Q2 2025 and 0.11% for Q1 2025.